Benzodiazepine tranquilizers abolish the stress-induced increase of the brain ghrelin level in DANIO RERIO

Danio reriohas firmly established itself as a successful model for research in many areas of biology and medicine, first of all for developing new medicines. The aimof our study was to evaluate ghrelin level in zebrafish brain after stress and after phenazepam usage on stressed fish. Methods.In our study 96Danio rerio, predatorCichlasoma nicaraguensishave been used. The fish have been kept at anormal room temperature (2223C) with standard feeding time (twice per day). The level of neuropeptides has been tested by ELISA test. During experiment a fish has been firstly placed in a beaker with a dissolved pharmacological substance, then has been transferred into a tank with predator. In the end of experiment, it has been put into a novel tank for 6 min. The decapitation has been made. Thebrain has been divided into three anatomical parts:telencephalonjust behind the olfactory bulb, the middle partcorpora bigemiaandcerebellum, which is situated behind thecorpora bigemia. After that the material for ELISA test was made using GhrelinFISH, MyBioSource ELISA kit. Results.In the control group ghrelin has been determined only in thecerebellumin 57.14% of all fish. In the experiment with predator ghrelin has been found in all tested brain parts of fish, but in thetelencephalonthere was the highest level. Inthe experiment with phenazepam usage only and phenazepam administration after predator stress, the ghrelin value has not been determined atall. Conclusion.Thus we have found out that the ghrelin value increases after predator stress and the drug phenazepam eliminated it completely after its administration. We may suppose that the administration of anxiolytics such as phenazepam can reduce the anxiety inDanio rerio.

Benzodiazepine tranquilizers abolish the stress-induced increase of the brain ghrelin level in DANIO RERIO

Danio reriohas firmly established itself as a successful model for research in many areas of biology and medicine, first of all for developing new medicines. The aimof our study was to evaluate ghrelin level in zebrafish brain after stress and after phenazepam usage on stressed fish. Methods.In our study 96Danio rerio, predatorCichlasoma nicaraguensishave been used. The fish have been kept at anormal room temperature (2223C) with standard feeding time (twice per day). The level of neuropeptides has been tested by ELISA test. During experiment a fish has been firstly placed in a beaker with a dissolved pharmacological substance, then has been transferred into a tank with predator. In the end of experiment, it has been put into a novel tank for 6 min. The decapitation has been made. Thebrain has been divided into three anatomical parts:telencephalonjust behind the olfactory bulb, the middle partcorpora bigemiaandcerebellum, which is situated behind thecorpora bigemia. After that the material for ELISA test was made using GhrelinFISH, MyBioSource ELISA kit. Results.In the control group ghrelin has been determined only in thecerebellumin 57.14% of all fish. In the experiment with predator ghrelin has been found in all tested brain parts of fish, but in thetelencephalonthere was the highest level. Inthe experiment with phenazepam usage only and phenazepam administration after predator stress, the ghrelin value has not been determined atall. Conclusion.Thus we have found out that the ghrelin value increases after predator stress and the drug phenazepam eliminated it completely after its administration. We may suppose that the administration of anxiolytics such as phenazepam can reduce the anxiety inDanio rerio.

Assessment of the Validity of the Psycho-Cardiological Comorbidity Index in the Practice of a Cardiologist

Background. The feasibility of creating a screening Index for the comorbidity of mental disorders and cardiovascular diseases in the practice of the cardiologist dictates the need to validate existing algorithms.Aim. To validate the previously proposed Index of psychocardiac comorbidity in prediction of outpatient recommendation of psycho-pharmacotherapy for cardiology patients.Materials and methods. Medical records of 302 consecutive patients of cardiac in-patient department were retrospectively analyzed with ROC-curve to estimate the predictive value of previously proposed Index of psychocardiac comorbidity for out-patient recommendation of psycho-pharmacotherapy.Results. The prevalence of outpatient psycho-pharmacotherapy in the examined patients was 15.2 %; this group of patients was more polymorbid and was characterized by a higher proportion of women and a higher prevalence of a labile course of arterial hypertension. The sedative antipsychotics, non-benzodiazepine tranquilizers and mood stabilizers were predominant pharmacological groups. An analysis of reproducibility of Index of psychocardiac comorbidity was provided on a cohort of cardiology in-patient department (n = 302). Index calculated by using the formula I = C + 3(6)×Q + 3×W + 8×A (C – number of Comorbid diagnoses, Q – Quake in the chest, palpitations or arrhythmia, onset before 55 (3 points) or 50 (6 points) years; W – Women; A – labile Arterial hypertension). Area under ROC-curve in validation cohort was 0.828 ± 0.035 (p < 0.001). Positive predictive value of Index was maximal for the score of ≥ 13.Conclusion. The proposed Index of psychocardiac comorbidity is a valid tool to predict the prescription of psychopharmacotherapy in cardiology patients.